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Genetic Monitoring of Human Polymorphic
Cancer Susceptibility Genes by Polymerase
Chain Reaction: Application to Glutathione
Transferase pA.
by Douglas A. Bell,' Claudia L. Thompson,' Jack
Taylor,2 Chris R. Miller,' Frederica Perera,3 Ling L.
Hsieh,4 and George W. Lucier'
Several genes involved in the metabolism of carcinogens have been found to be polymorphic in human
populations and are associated with increased risk of cancer at some sites. This study focuses on the
polymorphic enzyme glutathione transferase u (GT pu). Smokers with low lymphocyte GT p. activity are at an
approximately 2-fold higher risk for lung cancer and an approximately 3-fold higher risk for stomach and
colon adenocarcinomas. Recent cloning and sequencing of the GSTI gene has allowed the development of
convenient genotyping methods based on restriction fragment length polymorphisms (RFLP) or the polym-
erase chain reaction (PCR). The GSTI polymorphism has been shown to be a deletion of the gene locus. To
detect the presence or absence ofthe gene we amplified exons 4-5 and/or exons 6-7 ofthe GSTI gene by PCR.
PCR amplification produced bands of 215-bp or 273-bp from individuals with one or two copies ofthe GSTI
allele andnobandiftheindividual washomozygouslydeleted(0/0).Intheexon6-7PCR,weco-amplifieda268-
bp portion ofthe P-globin gene as an internal reference standard for quantitative analysis ofproduct yield.
This allowed homozygote individuals ( +/+) to be distinguished from heterozygotes ( +/0).
We have compared the GSTI genotype to lymphocyte GT p. activity measured on trans-stilbene oxide (TSO)
in the lymphocytes of 45 individuals. Low GT p. activity (< 67 pmole/min/107 cells) was strongly associated
(24/24) with the GSTI 0/0 genotype. With the exception of one individual, activities greater than 67 pmole/
min/107 were associated with the presence of the GSTI allele (20/21). Individuals with the highest GT-TSO
activitywerefoundtobehomozygousforGSTI ( +/ +),whileheterozygotes ( +/0)generallyhadloweractivity,
suggesting agenedosageeffectinlymphocytes.Thealleledistributionamongfoursampledpopulationsvaried
considerably. In a North Carolina population, 51% (65/127) were GSTI 0/0, and this finding is consistent with
those of other studies based on phenotypic analysis. In three smaller cohorts, the GSTI 0/0 genotype was
observed to occur in: 30% (14/47) of Finnish foundry workers, 33% (18/54) of Georgia dye workers, and 62%
(74/120) of Thiwanese placental samples. In the future, we shall investigate the mechanistic link between
polymorphisms in carcinogen metabolism genes and interindividual variation in measures ofDNA damage,
such as DNA adducts and hprt mutation frequency.
Introduction
Metabolic activation and detoxdfication pathways for car-
cinogens mediate the initial steps in environmental carcino-
genesis. Genetic differences in these pathways are likely
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tobe amajor source ofinterindividualvariation in suscep-
tibilityto cancer(1,2). Several genesinvolvedinthemetab-
olism ofcarcinogens havebeenfound to bepolymorphic in
humanpopulations, and specificalleles are associatedwith
increased risks ofcancer at various sites (1-4).
This study focuses on the polymorphic enzyme glu-
tathione transferase pu (GT p.). Smokers with lowlympho-
cyte GT ,u activity are at approximately2-fold higher risk
for lung cancer, particularly adenocarcinoma (3). In addi-
tion, there is a 3-fold higher risk of stomach and colon
adenocarcinoma amongindividualswith no detectable GT
p. enzyme, as determinedbystarchgelelectrophoresis (4).
The GT p. enzyme catalyzes theconjugation ofglutathione
to epoxides of polycyclic aromatic hydrocarbons, aflatox-BELL ET AL.
ins, and other compounds. In general, this is a detoxifica-
tion reaction and may be an important protective system
against exposure to these agents (5-7). In most human
studies, theGT ,upolymorphism hasbeencharacterized at
the phenotypic level, eitherbymeasuring enzyme activity
related to a specific chemical (i.e., trans-stilbene oxide
[TSO]) or by isolating and identifying isozymes (3,4).
Enzymeassays onisolatedlymphocytes canbelogistically
difficult and technically cumbersomewhen applied to pop-
ulation studies, and they require substantial quantities of
blood (10-30 mL).
Recent cloning and sequencing of the gene for GT pu
(GST1 gene) has allowed the development of convenient
genotypingmethodsbased onrestriction fragmentlength
polymorphisms (RFLP) or the polymerase chain reaction
(PCR) (8,9). PCR approaches are rapid and reliable, and
one can use DNA prepared from small numbers of cells
(102_106 cells, or 0.001-1.0 mL blood). These characteris-
tics are well suited to population studies involving large
numbers of samples and limited quantities of biologic
material (blood or tissue).
Ourlaboratory is studyingthe distribution ofhigh- and
low-risk alleles for cancer susceptibility in various expos-
ure groups and ethnic populations. We are looking for
associations between genotype and tumor incidence at a
variety ofsites, and also specific measures ofDNAdamage
such as mutation frequency and DNA adducts. In this
paper, we describe PCR approaches for detecting the
GST1 genedeletion, reportourcomparison ofPCRresults
with lymphocyte GT pu enzyme activity measurements,
and also report preliminary data on the distribution of
GST1 alleles in some ethnic and geographic populations.
Methods
Enzyme Assay
Peripheral blood from healthy individuals was collected
into Leucoprep (Becton-Dickinson) tubes, and lympho-
cyteswereisolatedbythestandardproceduredescribedin
the product literature. Lymphocytes were assayed imme-
diately for GT activity or frozen at -800C for up to 4
weeks. Liu et al. (7) reported that freezing had no impact
on GT-TSO activity. GT activity toward TSO was mea-
sured by the procedure of Seidegard and Pero (10), with
slight modifications as described by Liu et al. (7).
Genotype Analysis by Polymerase
Chain Reaction
DNA was extracted from 105-107 isolated lymphocytes
using the method of Miller et al. (11) and resuspended in
sterile distilled H20 or buffer (10 mM ITis, 1 mM EDTA)
andfrozen untiluse. PCRswerecarried outseparatelyfor
exons 4-5 and 6-7. DNA ('100 ng) from approximately
2 x 104 cells was added to a PCR mix composed of 30
pmole of each primer, 200 p.mole deoxynucleotide tri-
phosphates, 1 unit Taq polymerase (Amplitaq, Perkins-
Elmer Cetus, Norwalk, CT) and PCR buffer composed of
16.6 mM (NH4)2SO4, 50 mM 3-mercaptoethanol, 6.8 F.M
EDTA, 67 mM This (pH 8.8), 80 ,ug/mL bovine serum
albumin and 1.6 mM MgCl2 in a volume of 30 ,uL. In a
Perkin-Elmer Cetus Thermal Cycler, the reaction mix-
ture was denatured at 94°C for 3 min and subjected to 25
cyclesof94°Cfor1min;59°Cfor1minand72°Cfor1.5min.
A final 72°C extension for 5 min was performed. Samples
were electrophoresed on 3:1 Nusieve Agarose gels and
checked for the presence of bands. PCRs for exons 6-7
were also carried out in the presence of10-pmole primers
for the ,3-globin gene (Perkin-Elmer Cetus); following
electrophoresis, the ethidium bromide-stained gel was
photographed andanegativewasprepared. Densitometry
wascarriedoutonthephotographic negativewithanLKB
Gel Scan II scanning laser densitometer, and the ratio
between band intensities of the 3-globin and GST1 PCR
productswascharacteristicofthehomozygous (0.9-1.3) or
heterozygous genotype (0.5-0.8). Forallanalyses,positive
and negative control reactions were run in parallel to
check for reagant contamination.
Results and Discussion
The GT p. polymorphism was shown to be a deletion of
theentireGST1 genelocusbySiedegardetal. (9). Inorder
to detect the GT p. sequence polymorphism by PCR, we
used oligonucleotide primers that amplifyexons 4-5 (8,12)
or exons 6-7 of the GST1 gene. PCR amplification with
these primer sets produced 273-bp or 215-bp bands on
agarose gelsfromindividualswith one ortwocopies ofthe
GST1 allele, and no visible band if the individual was
homozygously deleted.
The exon and intervening intron regions of the GST1
genethatwereamplifiedbyPCRshownearly100%homol-
ogy with other functional and psuedo-GST p. loci (13-15).
In our hands, the PCR primer sequences of Comstock et
al. (8) for exons 4-5 often produced spurious PCR frag-
ments with lengths of approximately 100 bp or approx-
imately 265 bp, which appeared in samples from
individuals with no GT p, activity. These primers may not
adequately discriminate between the GST1 locus and the
highly homologous human muscle-specific GST4 locus or
the testis-specific GT p. locus, neither of which is poly-
morphic (13,15). Becauseofthisproblem,primersforexons
6and7weredesignedtodetecttheGST1 locusspecifically.
In PCRs for exons 6 and 7, primert for the ,B-globin gene
locus (Perkins-Elmer Cetus) were also included, for the
followingreasons. First,individualswiththedeletedGST1
genotype produce no PCR product; co-amplification of
,B-globin provides a convenient internal positive control
and allows relative quantification oftemplate DNA in the
reaction. This is particularly important for samples with
only small amounts of DNA, where a technical failure to
amplifywould be falselyinterpreted as homozygous dele-
tion. Second, the ,B-globinPCRproductwas alsoused as a
referencestandardforquantitativeanalysisoftheproduct
yieldfromtheGST1 amplification.Thisapproachwasused
byNeubauer etal. (16),who demonstrated thatbyoptimiz-
ing reagent concentrations the relative copy numbers of
two or more co-amplified genes could be determined by
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FIGURE 1.Agarose gelelectrophoresis ofpolymerase chain reaction products from co-amplification ofGSTi exons 6-7(215-hpband) and 13-globin gene
(268-hpband). Lane3washomozygouslydeleted (0/0); lanes1,4, and 5 wereheterozygotes (+/0); andlane2 washomozygous forthe GST1 gene (+/+)
Marker lane is HincII digest of0X174 DNA, bands are 1057-hp, 770-hp, 612-hp, 495-hp, 392-hp, 341-hp, 297-hp, 210-hp, and 162-hp.
quantifying their PCR product ratios. This allowed us to
distinguish homozygous wild-type from heterozygous
individuals.
Figure 1 demonstrates the band pattern on a 4% 3:1
NuSieve agarosegelthatresultedfromuseofthismethod.
The 268-bp band found in all samples (lanes 1-5) was the
PCRproductfromthe ,B-globin gene amplification. Ampli-
fication of GST1 exons 6-7 and the intervening intron
produced the215-bp fragment thatwas presentinlanes 1,
2, 4, and 5 but was absent in lane 3. Lane 3 shows the
homozygously deleted genotype. Quantification of the
band intensities in each lanebyscanninglaserdensitome-
try revealed the 3-globin:GST1 ratios for lanes 1-5 to be
0.65,0.98,0.0,0.66, and 0.54. The j3-globin:GST1 ratiosfor
lanes 1, 4, and 5 were characteristic of heterozygotic
individuals, while the higher ratio (0.98) in lane 2 was
characteristic ofhomozygotes.
WehavecomparedthePCR-determinedGST1 genotype
to GT ,u enzyme activity measured on TSO in the lympho-
cytes of45individuals andfoundgood agreementbetween
thesemethods.Theresults aredisplayed onFigure2. Bars
represent lymphocyte GT-TSO activity for each indi-
vidual; above each bar is the PCR result (0 = GST1
deleted; +/0 = one copy ofGSTi; +/+ = two copies of
GST1). The distribution of enzyme activity appears as a
continuum from low to high values. Individuals with GT-
TSO activities less than 67 pmole/min/107 cells were con-
sistently found to have the homozygously deleted gen-
otypebythe PCR assay(24/24). With the exception ofone
individual, subjects with activities greater than 67 pmole/
min/107 cells had at least one GST1 allele. The continuous
distribution ofenzyme activityshown in Figure 1 is differ-
ent from that found by Seidegard et al. (9,10), who
described a steplike distribution with low (< 25 pmole/
min/107 cells) and high (> 600pmole/min/107 cells) activi-
ties but no intermediate value. The difference may be due
to methodological differences in lymphocyte preparation.
The four individuals with the highest GT-TSO activity
(> 230 pmole/min/107 cells) were homozygous (two copies
ofthegene)forGST1 bythequantitativePCRassay.GST1
heterozygous individuals with activities of 72-145 pmole/
min/107 cells had a single copy of the GST1 gene. These
results are consistent with a gene dosage effect; however,
the relationship between GST1 copy number and enzyme
activity breaks down in the 150-200 pmole/min/107 cells
range, possibly owing to assay variation or to intrain-
dividual variation. The gene dosage effect that we ob-
served suggests that GSTi is expressed at a basal,
constitutive level in lymphocytes. On-going studies may
reveal whether gene dosage and level of enzyme activity
affectDNAadductlevelsormutationfrequencyinlympho-
cytes.
Preliminary results suggest that GT-TSO activity in
theliver(whichis10-foldhigherthaninlymphocytes) does
not differ between heterozygous and homozygous gen-
otypes (GST1 +/0, or +/+). This may indicate that for
detoxification reactions mediated through the liver, the
homozygousgenotype (GST1 +/+)isnotmoreprotective
than the heterozygous genotype (GST1 +/0). Because of
the high GT p. expression level in the liver, however, any
deleterious effect of the homozygous deleted genotype
(GST1 0/0) should be more apparent.
One individual with the homozygous deleted genotype
had unusually high activity and was assayed on three
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FIGURE 2. Distribution of lymphocyte glutathione-trans-stilbene oxide (GT-TSO) enzyme activity. Labels above bars indicate result of polymerase
chainreaction assayforGST1 (+ = GST1 present; +/0 = onecopyGST1; +/+ = twocopiesofGST1; 0 = GST1 deleted).Valuesareaveragesofone
to four individual determinations.
separate occasions approximately 3 months apart on
freshly isolated cells, producing values of144.3, 127.8, and
4.7 pmole/min/107 cells (mean = 92.6 pmole/min/107 cells).
The high activity (and variability) for this individual and
the significant activity (10-67 pmole/min/107 cells) for
other GST1-deleted individuals suggests that other
enzymes, possibly other GTs that are known to be
expressed at high levels in lymphocytes, may interfere
with the GT-TSO assay. If the high-activity individuals
possess large amounts of other GTs, it is plausible that
there may be some overlapping substrate specificity.
Published reports based on phenotypic methods sug-
gestthat30-60%ofU.S., European, andAsianpopulations
have the homozygously deleted GST1 genotype (4,6). In
our genotyping studies, the allele distribution among four
sampled populations varied considerably but was consis-
tent with previous reports. In a population in North Car-
olina, we observed that 51% (65/127) were GST1 homozy-
gously deleted. In three smaller cohorts, however, the
percentages with the homozygously deleted genotype
were: Finnish foundry workers, 30% (14/47); Georgia
(USA) dyeworkers, 33% (18/54); Taiwanese, 62% (74/120).
The divergent allele frequency distributions for these
population samples maybe related to ethnic orgeographic
patterns or to small sample size; however, ifthese distribu-
tions arereal, significantdifferencesinriskmayexistamong
regional and ethnic groups for adverse health effects from
exposure to polycyclic aromatic hydrocarbons.
The overall approach of our genotyping program is to
investigate the link between polymorphisms in genes for
carcinogen metabolism and interindividual variation in
measures of DNA damage, mutation frequency, and can-
cer incidence. In addition to studying the GT polymor-
phism, we are also genotyping for the debrisoquine
hydroxylase, N-acetyl transferase, and aryl hydrocarbon
hydroxylase polymorphisms. This genotypic analysis
should permit a clearer understanding ofthe relationship
between polymorphisms of genes involved in carcinogen
metabolism and individual susceptibility to the mutagenic
and carcinogenic actions ofspecific chemical exposures.
This manuscript was presented at the Conference on Biomonitoring
and Susceptibility Markers in Human Cancer: Applications in Molecular
Epidemiology and Risk Assessment that was held in Kailua-Kona,
Hawaii, 26 October-i November 1991.
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